Maxim Group Upgrades Kiora Pharmaceuticals (KPRX) to Buy
Tweet Send to a Friend
Maxim Group analyst Michael Okunewitch upgraded Kiora Pharmaceuticals (NASDAQ: KPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
